Method of using exendin and GLP-1 to affect the central nervous system
Patent Number: 5846937
Date of First Priority Issue: Monday March 3rd, 1997
Date Issued: Tuesday December 8th, 1998
Assignee: 1149336 Ontario Inc. (Toronto, CA)
Inventor: Drucker, Daniel J. (Toronto, CA)
From Class: Use
Comments: No comments
This patent may be interesting for Amylin from San Diego to look at. Why it is interesting is because, I believe, Amylin actually has taken some of the compounds described in this patent to the clinic.
This patent teaches the use of GLP-1 and/or exendin-4 for modulation of central nervous system activity.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.